FDA approves pancreatic cancer pill as Tyler patient sees results in similar clinical trial
FDA approves pancreatic cancer pill as Tyler patient sees results in similar clinical trial KLTV.com
Regulatory Approvals
FDA Approves Brepocitinib as First Oral Drug for Dermatomyositis
FDA Approves Brepocitinib as First Oral Drug for Dermatomyositis The American Journal of Managed Care
US FDA approves Roivant-Priovant’s skin and muscle disease drug
US FDA approves Roivant-Priovant's skin and muscle disease drug Reuters
FDA Approves Brepocitinib for Dermatomyositis
FDA Approves Brepocitinib for Dermatomyositis Dermatology Times
FDA Approves First Oral Drug Indicated to Treat Dermatomyositis in Adults
The U.S. Food and Drug Administration has approved Lisraya (brepocitinib) tablets for the treatment of dermatomyositis in adults.